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Background: Male wild type (WT) C57BL/6 mice are less capable of clearing bacteria and surviving from bacterial
pneumonia than females. However, if an oxidative stress (acute ozone exposure) occurs before infection, the
advantage shifts to males who then survive at higher rates than females. We have previously demonstrated that
survival in surfactant protein-A (SP-A) knockout (KO) mice compared to WT was significantly reduced. Because the
alveolar macrophage (AM) is pivotal in host defense we hypothesized that SP-A and circulating sex hormones are
responsible for these sex differences. We used 2D-DIGE to examine the relationship of sex and SP-A on the AM
proteome. The role of SP-A was investigated by treating SP-A KO mice with exogenous SP-A for 6 and 18 hr and
studying its effects on the AM proteome.
Results: We found: 1) less variance between KO males and females than between the WT counterparts by principal
component analysis, indicating that SP-A plays a role in sex differences; 2) fewer changes in females when the total
numbers of significantly changing protein spots or identified whole proteins in WT or 18 hr SP-A-treated males or
females were compared to their respective KO groups; 3) more proteins with functions related to chaperones or
protease balance and Nrf2-regulated proteins changed in response to SP-A in females than in males; and 4) the
overall pattern of SP-A induced changes in actin-related proteins were similar in both sexes, although males had
more significant changes.
Conclusions: Although there seems to be an interaction between sex and the effect of SP-A, it is unclear what the
responsible mechanisms are. However, we found that several of the proteins that were expressed at significantly
higher levels in females than in males in WT and/or in KO mice are known to interact with the estrogen receptor
and may thus play a role in the SP-A/sex interaction. These include major vault protein, chaperonin subunit 2 (beta)
(CCT2), and Rho GDP alpha dissociation inhibitor. We conclude that sex differences exist in the proteome of AM
derived from male and female mice and that SP-A contributes to these sex differences.
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LungIntroduction
A growing number of studies have described sex diffe-
rences in the incidence and severity of pulmonary diseases
[1-4]. Perhaps the most thoroughly characterized of these
are COPD [5-8] and asthma [9-11]. Sex differences have* Correspondence: jfloros@psu.edu
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reproduction in any medium, provided the oralso been reported in the incidence of some pneumonias,
although these data are not as straightforward [12-15].
However, despite this increasing recognition of sex diffe-
rences serious gaps remain in our understanding of the
responsible mechanisms.
A number of laboratories including our own, have em-
ployed animal models to study sex differences in pul-
monary disease [16]. These studies include models for
COPD, asthma [17,18], fibrosis [19], pneumonia [20-22],
and others. Our studies with mice infected with Klebsiella
pneumoniae found sex differences in the susceptibility toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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when mice were infected after being exposed to ozone,
the sex differences went in the opposite direction (females
more affected than males) [20]. Ozone-exposed K. pneu-
moniae-infected females showed an excessive lung inflam-
matory response compared to their male counterparts
[22]. In the absence of ozone exposure, males had higher
levels of bacterial dissemination compared to females,
whereas in ozone-exposed females, the bacterial clearance
in the lung was decreased more than in males [23]. Circu-
lating sex hormones (estrogen, dihydrotestosterone; DHT)
were recently shown to play a role in these survival diffe-
rences [24]. Comparison of K. pneumoniae-infected mice
lacking surfactant protein A (SP-A)(SP-A knockout; KO)
to wild type (WT) mice on the C57BL/6 genetic back-
ground showed a poorer survival rate [21] with the sex
differences persisting in the presence of ozone-induced
oxidative stress.
SP-A is a collagenous lectin or collectin that is known
to influence host-defense function in the lung in a num-
ber of ways [25,26]. These include its ability to function
as an opsonin aiding in the clearance of a variety of patho-
gens by alveolar macrophages (AM), to influence the pro-
duction of inflammatory mediators by lung immune cells,
and to alter the expression profile of the bronchoalveolar
lavage (BAL) proteome in the lung [27,28].
The AM plays a pivotal role in innate host defense
function. AM from male mice have been shown to have
significantly higher phagocytic indices in response to in-
fection with K. pneumoniae than females after exposure
to ozone [20]. Similar observations have been made for
AM from SP-A KO mice, except that the phagocytic in-
dices were lower than those from WT AM, indicating
that macrophage function was impaired in the absence
of SP-A [21]. Recently we showed that SP-A has a sig-
nificant impact on the AM proteome in males [29].
In an effort to better understand the basis for the
differences in macrophage function in the presence or
absence of SP-A and between males and females we
studied the AM proteome. The proteome of AM from
females as well as a comparison of the proteome from
male [29] and female WT mice and KO mice that received
exogenous SP-A was studied using two-dimensional diffe-
rence gel electrophoresis (2D-DIGE) coupled with MALDI-
ToF/ToF, and the Ingenuity Pathways Analysis program.
Results
Overview
The proteomics study of AM from male [29] and female
(present study) WT and KO mice was performed as a
single proteomics experiment, thereby allowing us to di-
rectly compare the data. The data for the male AM were
previously analyzed and published along with a proof of
principle experiment demonstrating SP-A effects on theactin cytoskeleton [29]. In this report the focus is on: a)
the study of the data from female AM; and b) the com-
parison of changes in the female and male AM pro-
teomes in response to exogenous SP-A treatment of SP-A
KO mice.BAL and cells
Cell pellets were examined from all BAL samples and
underwent total and differential cell counts to exclude
the possibility that any of the mice had underlying infec-
tious or inflammatory processes. No evidence of inflam-
mation or infection was seen in any of the mice. There
were no significant differences in total cell counts and
all BAL samples consisted of > 95% macrophages (data
not shown). Protein content was the same in all samples
(data not shown) and identical amounts of protein (20 μg)
from each sample were loaded on all analytical gels.2D-DIGE results
Overview
Gels from the 2D-DIGE study were subjected to auto-
matic spot detection using the Progenesis SameSpots
program, after which we performed manual editing. This
resulted in 791 protein spots that were matched across
2D-DIGE gels from all samples. Statistical analysis was
then done on the individual protein spots. Statistical com-
parisons were done between the experimental groups of
each sex (e. g. KO versus WT) and between sexes for each
experimental condition (e. g. male KO versus female KO).
Principal component analysis (Figure 1) of the 172 gel
spots that differed by ANOVA (p > 0.05) offered an over-
view of the data and showed that the four experimental
groups of female mice were relatively well grouped with
no overlap between groups. The two steady-state groups
(KO and WT) were the best separated and most tightly
clustered groups. The two female SP-A-treated (6 hr and
18 hr) groups were more closely associated to one another
indicating less variance between these groups during the 6
and 18 hr treatment intervals. This lack of clear separation
between some members of these treatment groups may
reflect differences in response kinetics among individuals
in each group. We then picked all 791 of the individual
protein spots from a preparative gel and subjected then to
MALDI-ToF/ToF resulting in the identification of 76 dis-
tinct proteins (See Additional files 1 and 2 – these have
been published previously [29]). The values for all gel
spots representing a given protein were added together
and additional statistical analysis, including a series of
pairwise comparisons, was then done on all identified pro-
teins. In Table 1 all proteins with significant increases and
decreases relative to untreated KO protein levels in at
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Figure 1 Principal component analysis of different treatment groups. A plot of the principal component analysis for the 172 significant
(ANOVA, p < 0.05) protein spots is shown. The markers represent the weighted average for the first two principal components for the 172
proteins for each individual in each of the groups: SP-A knockout (KO) (), SP-A knockout treated with SP-A for 6 hr (KO 6 hr SP-A) (▲), SP-A
knockout treated with SP-A for 18 hr (KO 18 hr SP-A) (♦), and wild type (WT) (■).
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MALDI-ToF/ToF was used to analyze all 791 detected
gel spots and resulted in the identification of 290 spots
(comprising 76 unique proteins) with confidence inter-
vals > 95% and ProteinPilot scores of > 61. These have
been described in a previous publication [29] and the in-
formation about the proteins and a reference gel are
included as supplementary material (see Additional files
1 and 2). Some of these identified proteins consisted of a
single gel spot and others consisted of multiple spots
representing isoforms of a specific protein. The values of
all spots for a given protein were added together and
statistical analysis done on the combined value. Normal-
ized volumes for all identified proteins are given and
values were compared between female groups and sig-
nificant differences are listed in Additional file 3.
As in previous publications and other types of samples
(BAL proteins, plasma proteins) we used different ap-
proaches [27-30] to assess the function of the 76 iden-
tified proteins and their biological relevance to AM
function. Some functional information was provided by
analyzing the data with the Ingenuity Pathways Analysis
(IPA) program. These analyses identified proteins invol-
ved in several processes: 1) regulation of actin-based
motility (p = 6.85E-08); 2) RhoA signaling (p = 3.98E-07);
3) actin cytoskeleton signaling (p = 3.35E-06); 4) Fcγ
receptor-mediated phagocytosis (p = 3.36E-06); and 5)
clathrin-mediated endoctyosis signaling (p = 6.11E-05),
comprising the five top canonical pathways. In addition
the Nrf2-mediated oxidative stress response (p = 1.09E-04)
was prominent among the processes implicated by IPA.Furthermore, we employed a manual curation approach,
emphasizing findings from the literature related to the
lung and macrophages, where available. These approaches
strongly implicated motility, phagocytosis, actin signaling,
RhoA signaling, and endocytosis (which we retained as a
single functional group of “actin-related/cytoskeletal pro-
teins” rather than dividing it into 5 subgroups) as the most
involved cellular processes and included 38 of the 76 pro-
teins identified in our study (Additional file 1 [31-99]).
Given the role of the AM as a mobile phagocyte, this was
anticipated and the identification of a substantial subset
of identified proteins involved in these processes indi-
cates that SP-A plays a pivotal role in these macrophage
functions.
The Nrf2-related protein category included 21 of our
identified proteins. Other major cellular processes impli-
cated by our list of identified proteins included regu-
lation of inflammation (20 proteins), protease balance/
chaperone function (19 proteins), and regulatory/differ-
entiative processes (8 proteins). These functional groups
also represent important facets of AM biology and the-
reby constitute a valuable tool in assessing macrophage
function in the presence or absence of SP-A. Protease/
chaperone function may be very important in the repair
of damage to lung tissue and proteins potentially result-
ing from exposure to noxious material, pathogens, or
other danger signals. Similarly, the regulation of inflamma-
tory processes is extremely important for innate immune
processes, with dysregulation of inflammation playing
a central role in many pulmonary disease processes. Fi-
nally, the profound differences between circulating blood
Table 1 Significant changes in alveolar macrophage proteins for Female mice (as compared to KO baseline)
Gel no. Protein name KO 6 hr SP-A Female KO 18 hr SP-A Female WT Female
5 Alpha-fetoprotein ↑* ↑ ↑
8 Anxa5 protein ↑ ↓ ↑*
11 Calpain, small subunit 1 ↑ ↓* ↓
12 Capping protein (actin filament) muscle Z-line, alpha 2 (CapZ alpha-2) ↓* ↓* ↓
13 Capping protein (actin filament) muscle Z-line, beta isoform a (CapZ beta) ↓* ↓ ↓
24 Eno1 protein (Alpha-enolase) ↑* ↑ ↑
25 Eukaryotic translation initiation factor 5A ↑ ↑* ↑
26 Ezrin ↓* ↓ ↓
29 Ferritin light chain 1 ↓ ↓ ↓*
30 Gamma-actin ↓ ↓* ↓
34 Heat shock protein 1, beta (HSP90AB1) ↓* ↓ ↓*
35 Heat shock protein 5 precursor (GRP78) ↑ ↑ ↓*
40 Heme-binding protein ↓* ↓ ↓*
41 Heterogeneous nuclear ribonucleoprotein K ↓* ↓ ↓
45 Keratin complex 2, basic, gene 8 ↓ ↑ ↑*
52 Nucleophosmin 1 ↓ ↓* ↓*
53 p50b ↓* ↓ ↓
55 Prolyl 4-hydroxylase, beta polypeptide precursor ↑* ↑* ↓
56 Proteasome (prosome, macropain) 28 subunit, alpha ↑* ↑ ↑*
61 Purine nucleoside phosphorylase ↑* ↑ ↑*
64 Rho GDP dissociation inhibitor (GDI) alpha ↑ ↑* ↑*
67 Stathmin ↑ ↑* ↑*
74 Vacuolar adenosine triphosphatase subunit B ↑* ↑ ↑
76 Vimentin ↓ ↓* ↓
Total significant changes 7↓*, 6↑* 5↓*, 4↑* 5↓*, 6↑*
Comparison of mean normalized volumes (see Additional file 3) for proteins from female KO mice to KO 6 hr SP-A, KO 18 hr SP-A, and WT mice. Increased compared
to KO(↑), decreased compared to KO(↓), determined to be significant (p < 0.05) by t-test (*). Changes in all proteins are given in Additional file 4 - Table F.
Phelps et al. Proteome Science 2012, 10:44 Page 4 of 15
http://www.proteomesci.com/content/10/1/44monocytes and the AM [100-102] and between macro-
phages that have undergone different modes of activation
[100,103], indicate the presence of an active regulatory
mechanism directing the differentiation of macrophages
from monocytes and their activation in various directions.
The functional groups to which each protein was assigned
are listed in Additional file 1. Note that some proteins are
included in more than one group.
AM proteome differences under baseline conditions and
in response to SP-A
a) Comparison between female WT and KO mice:
When AM from WT female mice were compared to
AM from KO females (Table 1) 5 proteins were at
significantly lower levels in the WT mice versus KO.
There were 6 proteins that had significantly higher
levels of expression in WT animals than in KO.
When KO mice were treated with exogenous SP-A
there were changes in levels of protein expressionthat approximate the WT profile indicating that SP-
A treatment tends to restore the WT phenotype. At
6 hours after treatment there were 7 proteins
expressed at significantly lower levels than the KO
mice and 6 that were expressed at higher levels than
in KO. By 18 hours this trend persisted and 5
proteins were at lower levels and 4 at higher levels
resulting in a picture similar to the differences
between WT and KO described above.
The significant changes in the expression of
identified proteins are summarized in Figure 2A and
in Table 1. A complete list of all proteins showing
how they change is in Additional file 4 – Table F. A
similar pattern was seen when significant changes in
individual gel spots are summarized (Figure 2B).
These summary diagrams show the differences
between the comparisons in female mice (front bars)
and from male mice (back bars) [29]. There were
many more significant changes in the males,
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Figure 2 Summary of significant changes in whole proteins and gel spots. In Panel A the graphs depict the number of significant changes
in identified proteins (from a total of 76) compared to KO in macrophages from female mice. The black bar represents the total significant
changes, the white bars represent significant decreases relative to KO, and the gray bars represent significant increases relative to KO. The
histograms on the right depict significant changes between WT and 18 hr SP-A treated mice. Bars in the front are the values from females
(present study) and bars in the back are values from males that we have previously published [29] and are shown here for comparison purposes.
In Panel B similar comparisons are shown for the gel spots.
Phelps et al. Proteome Science 2012, 10:44 Page 5 of 15
http://www.proteomesci.com/content/10/1/44versus KO comparisons. Furthermore, decreases
relative to the KO mice predominate in the males,
while females had roughly equal numbers of
decreasing and increasing proteins/spots.
The comparisons above demonstrate that 18 hr after
SP-A treatment of KO mice many aspects of the
female AM proteome resembled those seen in WT
mice. Statistical comparisons of the 18 hr point with
WT mice (right hand panels of Figure 2) showed
that the number of significant differences between
the 18 hr point and WT were more similar in males
and females than the differences observed in the
comparisons versus KO mice shown in the left hand
panels of Figure 2.
b)Differences between males and females: Comparison of
baseline levels of WTand KO mice from each sex
(data for male mice were from our previous study
[29]) identified 218 gel spots by ANOVA that differed
significantly. A principal component analysis of these
spots revealed that all groups were fairly well
consolidated with no overlap (Figure 3). There
appeared to be more of a difference between the male
and female WT mice, indicating greater variance
between them than between the two KO groups,
which were very close to one another. This seems to
be in general agreement with the whole protein data
for the WT mice (Figure 4A; Table 2) where
significant differences were observed for 11 of the 76
identified proteins with 10 of these proteins increasedand only 1 decreased in females. Indeed when gel
spots were analyzed there were 89 spots that differed
significantly in WTAM between male and female
mice, including 28 decreases (lower in female) and 61
increases (higher in female) (Figure 4B).
A very different situation was seen in the KO mice
where significant differences between male and
female KO mice were observed with 5 proteins, less
than half the number of significantly changing
proteins observed in WT (n = 11) (Table 2;
Figure 4A). Also, there were more than 3 times as
many protein spots expressed at significantly higher
levels in males (n = 27 gel spots) than in females (n =
7 gel spots)(Figure 4B). Consistent with these
findings, in the two SP-A treated groups there were
relatively few significant differences (6 proteins)
between male and female at 6 hr of treatment, but
many more significant changes (20 proteins) in the
18 hr SP-A treatment group (Figure 4A). The trend
of significant increases or decreases was similar in
both individual protein spots (Figure 4B) and in whole
proteins (Figure 4A).
Gel map overview of protein changes between males and
females of WT and KO AM under baseline conditions
Figure 5 shows two identical reference gels with diffe-
rences in protein spots between males and females out-
lined with either green when lower in females or red if
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Figure 4 Summary of significant sex differences in changes in
whole proteins and gel spots. In Panel A the graphs depict the
number of significant changes in whole proteins (from a total of 76
proteins) when males are compared to females. The black bars
represent the total significant changes, the white bars represent
significant decreases in females relative to males, and the gray bars
represent significant increases in females relative to males. In Panel
B similar comparisons are shown summarizing the data from gel
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Figure 3 Principal component analysis of male and female
baseline groups. A plot of the principal component analysis for the
218 significant (ANOVA, p < 0.05) protein spots differing between
females and males is shown. The markers represent the weighted
average for the first two principal components for the 218 proteins
for each individual in each of the groups: Female WT (), male WT
(■), female KO (○),
male KO (□).
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pict sex differences in KO mice and WT mice, respec-
tively. As shown previously in Table 2 and Figure 4,
there were very few significant sex differences in the KO
mice (solid green or red in Figure 5A) even though more
than twice as many proteins were at lower levels in the
female than in their male counterparts. By contrast, in
the WT mice (Figure 5B) there were approximately the
same numbers of proteins at lower levels in females
(green spots) as there were higher in females (red spots);
many more of the sex differences were significant, and
most of those changes were higher in females.
Examples of AM proteome patterns in males and females in
response to SP-A treatment
Several patterns of changes in response to SP-A were
seen. Stathmin (Figure 6A), a protein that regulates mi-
crotubule dynamics [104], was significantly higher in WT
AM of both sexes than KO AM, and showed increases
over KO levels after SP-A treatment in the female but
little or no change in the male. With nucleophosmin
1 (Figure 6B), WT levels were lower than KO levels
(significantly in females) and there was a time-dependent
decrease after SP-A treatment. The levels of keratin com-
plex 2, basic gene 8 (Figure 6C), a protein involved in
intermediate filament formation [76], were significantly
higher in WT than KO in both sexes, and neither sex
showed any apparent change after SP-A treatment.Coactosin-like 1 (Figure 6D), a protein known to bind
F-actin and serve as a chaperone for 5-lipoxygenase,
increased after SP-A treatment in males but appeared to
change little in females (Figure 6D).
Sex differences in functional groups
The proteins making up each of our functional groups
were studied in order to determine whether there were
fundamental differences between male and female WT
and KO AM and in response to SP-A treatment in these
groups, and whether these differences could explain the
differences we have previously reported in pneumonia
survival and phagocytic function. The data used for the
functional groups below are presented in Additional file 5
Tables A – E (see also Table 2 and Additional file 3). As
shown in Table 2 for all of the significantly changed pro-
teins in the WT mice, there were significant sex diffe-
rences where in almost all cases (10 of 11) female levels
exceeded male levels. In contrast, in KO mice only 5
proteins differed significantly between male and female
(3 higher in female; 2 in male). By 18 hours after SP-A
treatment 20 proteins differed significantly between male
and female (11 higher in female; 9 in male). Comparisons
Table 2 Significant changes in alveolar macrophage proteins from male to female mice in the same group
Gel no. Protein name KO KO 6 hr SP-A KO 18 hr SP-A WT
6 Annexin A2 ↓* ↓ ↓ UN
7 Annexin A4 ↓ ↑ ↓* ↓
8 Anxa5 protein ↓ ↓ ↓* ↓
12 Capping protein (actin filament) muscle Z-line, alpha 2 (CapZ alpha-2) ↓ ↓ ↓* ↓
15 Chaperonin subunit 2 (beta) (CCT2) ↑ ↑ ↑ ↑*
17 Chitinase 3-like 3 precursor (Ym1) UN ↑ ↑* ↑*
20 Chloride intracellular channel 4 (mitochondrial) ↓ ↑ ↓* ↓
22 Coactosin-like 1 ↓ ↓ ↓* ↓
33 Guanine deaminase ↑* ↑* ↑* ↑*
34 Heat shock protein 1, beta (HSP90AB1) ↑* ↑ ↑* ↑
35 Heat shock protein 5 precursor (GRP78) ↑* ↑ ↑* ↑
36 Heat shock protein 65 (HSP60) ↑ ↑ ↑* ↑*
38 Heat shock protein 90, beta (Grp94), member 1 ↓ ↑ ↑* ↑
40 Heme-binding protein UN ↓* UN ↓
49 Major vault protein (MVP) ↑ ↑ ↑* ↑*
50 Microtubule-associated protein, RP/EB family, member 1 ↓ ↓ ↑* ↑*
55 Prolyl 4-hydroxylase, beta polypeptide precursor ↓* ↓ ↓ ↓
59 Protein disulfide-isomerase A3 precursor ↑ ↑* ↑ ↑
60 Protein synthesis initiation factor 4A ↓ ↑ ↑* ↑*
62 Put. beta-actin (aa 27–375) ↓ ↓ ↓* ↓
63 Rab GDP dissociation inhibitor beta ↓ ↑ ↑ ↑*
64 Rho GDP dissociation inhibitor (GDI) alpha ↓ ↑ ↑* ↑*
69 Tropomodulin 3 ↓ ↓* ↓* ↓
70 Tropomyosin 3, gamma ↓ ↓ ↓* ↓
71 Tubulin, beta 5 ↓ ↓* ↓ ↓*
75 Valosin-containing protein ↑ ↑ ↑* ↑*
76 Vimentin ↓ ↓* ↓* ↓
Total significant changes 2↓*, 3↑* 4↓*, 2↑* 9↓*, 11↑* 1↓*, 10↑*
Comparison of mean normalized volumes (see Additional file 3) for proteins from male to female mice in the same group (KO, KO 6 hr SP-A, KO 18 hr SP-A, and
WT). Higher in female (↑), lower in female (↓), unchanged (UN), determined to be significant (p < 0.05) by t-test (*). Changes in all proteins are given in Additional
file 5 -Table F.
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male are shown in Additional file 5- Table F. Next we stu-
died these changes in the individual functional groups.
a) Protease balance/chaperone function group:
The most striking sex-related observation in this
functional group was the fact that of the 12
significant differences between the sexes in all groups
(KO, 6 hr SP-A, 18 hr SP-A, WT) there was only 1
(18 hr SP-A) in which male levels exceeded female
levels. Eleven of the 12 significant differences were in
chaperones and heat shock proteins and all 11 were
significantly higher in females. These results indicate
that chaperone function may be increased in females
although it is unclear how this would affect cellularstresses. It is also worth noting that of the 12
significant sex differences, half were seen in the
18 hr SP-A treatment group (Additional file 5 –
Table A).
In terms of the sex specificity of the SP-A response
patterns there were almost twice as many
significant differences in males (n = 17)[29] than in
females (n = 8)(Additional file 4 – Table A).
b) Actin-related/cytoskeleton group: Of the 38 proteins
characterized as actin-related/cytoskeletal most of
the significant differences between sexes in WT
mice were higher in the female (7 out of 8). In
contrast, the KO AM gave a markedly different
picture with 2 proteins that were significantly
higher in females and only 1 in males. As in the
Figure 5 Sex differences in protein levels in KO and WT mice. Two identical reference gels (see also Additional file 2) are shown in Figure 5.
Protein spots circled in green are expressed at lower levels in females and those with a red border are at higher levels in females. Significant
changes are indicated by filled green or red circles. Panel A shows the male versus. female comparisons in KO mice and Panel B shows the
differences in WT mice. The numbers adjacent to each spot indicate the protein and the names are listed below and correspond to those in
Additional file 2: 1, 65-kDa macrophage protein; 2, Actin related protein 2/3 complex, subunit 5; 3, Actin-related protein 3; 4, Actr2 protein; 5,
Alpha-fetoprotein; 6, Annexin A2; 7, Annexin A4; 8, Anxa5 protein; 9, ArsA arsenite transporter, ATP-binding, homolog 1; 10, Atp5b protein; 11,
Calpain, small subunit 1; 12, Capping protein (actin filament) muscle Z-line, alpha 2; 13, Capping protein (actin filament) muscle Z-line, beta
isoform a; 14, Cathepsin D precursor; 15, Chaperonin subunit 2 (beta); 16, Chia protein; 17, Chitinase 3-like 3 precursor; 18, Chitinase-related
protein MCRP; 19, Chloride intracellular channel 1; 20, Chloride intracellular channel 4; 21, CNDP dipeptidase 2; 22, Coactosin-like 1; 23, EF hand
domain containing 2; 24, Eno1 protein (Alpha-enolase); 25, Eukaryotic translation initiation factor 5A; 26, Ezrin; 27, F-actin capping protein alpha-1
subunit; 28, Ferritin heavy chain 1; 29, Ferritin light chain 1; 30, Gamma-actin; 31, Gelsolin precursor; 32, Glucose-6-phosphate dehydrogenase
X-linked; 33, Guanine deaminase; 34, Heat shock protein 1, beta; 35, Heat shock protein 5 precursor; 36, Heat shock protein 65; 37, Heat shock
protein 8; 38, Heat shock protein 90, beta (Grp94), member 1; 39, Hematopoietic cell specific Lyn substrate 1; 40, Heme-binding protein; 41,
Heterogeneous nuclear ribonucleoprotein K; 42, High mobility group 1 protein; 43, Hnrpf protein; 44, Kappa-B motif-binding phosphoprotein; 45,
Keratin complex 2, basic, gene 8; 46, Keratin type II; 47, Krt13 protein; 48, Laminin receptor; 49, Major vault protein (MVP); 50, Microtubule-
associated protein, RP/EB family, member 1; 51, Myosin light chain, regulatory B-like; 52, Nucleophosmin 1; 53, p50b; 54, Peroxiredoxin 2; 55, Prolyl
4-hydroxylase, beta polypeptide precursor; 56, Proteasome (prosome, macropain) 28 subunit, alpha; 57, Proteasome alpha 1 subunit; 58, Protein
disulfide isomerase associated 6; 59, Protein disulfide-isomerase A3 precursor; 60, Protein synthesis initiation factor 4A; 61, Purine nucleoside
phosphorylase; 62, Put. beta-actin (aa 27–375); 63, Rab GDP dissociation inhibitor beta; 64, Rho GDP dissociation inhibitor (GDI) alpha; 65, Rho,
GDP dissociation inhibitor (GDI) beta; 66, Serine (or cysteine) proteinase inhibitor, clade B, member 1a; 67, Stathmin; 68, Superoxide dismutase 1,
soluble; 69, Superoxide dismutase 1, soluble; 70, Tropomyosin 3, gamma; 71, Tubulin, beta 5; 72, Tyrosine 3/tryptophan 5 -monooxygenase
activation protein, epsilon polypeptide; 73, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide;
74, Vacuolar adenosine triphosphatase subunit B; 75, Valosin-containing protein; 76, Vimentin.
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half (13 of 28) of the significant changes relative
to KO values were in the 18 hr time point
(Additional file 5 – Table B).
However, in the actin-related/cytoskeletal protein
group there were fewer significant changes between
KO, WT, and the treatment groups in the female
mice (n = 17)(Additional file 4 – Table B) than in the
male mice (n = 32)[29] suggesting a more SP-A-
responsive actin-related protein group in the males
c) Nrf2-related protein group: Sex differences were also
apparent in the Nrf2-regulated proteins (Additional
file 5 – Table C). Although in WT there were only 3
significant differences (2 higher in females; 1 in
males) between males and females, at 18 hr afterSP-A treatment there were 8 (5 higher in females; 3
in males).
The Nrf2-related proteins also had very different
sex-specific response patterns with a total of 7
significant differences in the female (Additional file 4 –
Table C), but 17 [29] in the male.
d)Other groups: There were relatively few (n = 2) sex
differences in the regulatory/differentiative proteins
(Additional file 5 – Table D). This group also had
very few significant differences when KO were
compared to the WT and SP-A treatment groups in
both females (Additional file 4 – Table D) and males
[29]. In the regulation of inflammation proteins
(Additional file 5 – Table E) more sex differences































Figure 6 Examples of protein patterns. Graphs shown in Panels A-D indicate different SP-A-response patterns for: A) stathmin; B)
nucleophosmin 1; C) keratin complex 2, basic, gene 8; and D) coactosin-like 1. Significant differences (p < 0.05) are indicated by brackets.
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http://www.proteomesci.com/content/10/1/44found in mice treated for 18 hr with SP-A.
Comparing the SP-A response patterns showed the
females to have slightly fewer (n = 10) significant
changes versus KO than in the males (n = 14) [29].
Changes in proteins involved in estrogen action
Some of the identified proteins have known roles in
mediating estrogen activity. These include major vault
protein [105], chaperonin subunit 2-(beta) [106], alpha
enolase [107], Rho GDP dissociation inhibitor alpha [108],
and heat shock protein 1-beta (HSP90AB1) [109]. Several
of these proteins were expressed at significantly higher
levels in female WT mice than in male WT (major vault
protein, chaperonin subunit 2-beta, and rho GDP dissoci-
ation inhibitor alpha). Alpha enolase and heat shock pro-
tein 1-beta were not significantly different.
Discussion
Male WT C57BL/6 mice in response to K. pneumoniae
infection exhibit a higher level of bacterial dissemination
[23], more pronounced extrapulmonary lesions in liver
and spleen [22], and lower survival rates than their
female counterparts [20]. However, when an oxidative
stress, in the form of acute ozone exposure, is imposed
prior to infection, the survival advantage shifts to the
males and they survive at higher rates than the females
[20] who develop a more excessive lung inflammatory
response compared to males [22]. We hypothesized that
SP-A and circulating sex hormones are responsible forthese sex differences. Our recent studies indicate a role
of sex hormones in the observed sex differences [24].
Because of the pivotal role of the AM in alveolar host
defense, in this study, we used 2D-DIGE to examine the
interaction of sex and SP-A on the proteome of the AM.
The role of SP-A was studied by treating SP-A KO mice
with exogenous SP-A for 6 and 18 hr and studying the
resulting effects on the AM proteome. We have previ-
ously reported the results obtained when AM from male
mice were analyzed [29]. Here we analyzed the results in
AM from females and compared them with the males.
The most striking aspect of this study was the fact that
the effect of SP-A had very different characteristics in
females than in males. This manifested itself in several
ways. When the total numbers of significantly changing
protein spots and identified whole proteins were exam-
ined, in females there were many fewer changes in the
18 hr SP-A treatment and WT groups when each was
compared to KO as opposed to what we observed for
the males (Figure 2 and Table 2 versus our previously
published study in males (see Additional file 2 in [29])).
Furthermore, the principal component analysis that
compared male and female WT and KO mice showed a
much greater separation between the male and female
WT groups than the KO groups, indicating that SP-A
may play a role in the observed sex differences.
Our previous study of male AM showed that many
proteins are lower in AM [29] from WT mice than in
KO. These findings could reflect either an SP-A-
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pensation for the absence of SP-A. In either case, many
proteins are increased in KO mice. However, this trend
is less pronounced in AM from female mice (Table 1)
and there are only about half as many significant diffe-
rences (in all comparisons to KO) as there are in male
AM. Direct comparison of males [29] and females (present
study) in response to SP-A revealed sex differences. There
were equal numbers of proteins at their highest levels in
WT male and female, but in KO mice (in the absence of
SP-A) ~70% of the changing proteins were higher in the
males, although few of these reached statistical signi-
ficance. This may indicate that while SP-A plays an im-
portant role in AM protein expression, its effect is more
pronounced in the male and somewhat more limited in
the female. This scenario is consistent with reports sho-
wing an inhibitory effect of estrogen on inflammatory pro-
cesses in lung and other systems [110,111].
The most responsive group of proteins in response to
SP-A was that related to actin function, which consisted
of 38 proteins and underwent the most changes. How-
ever, the SP-A-induced changes were very similar in
males and females, although there were more significant
differences in males. Furthermore, SP-A response pat-
terns in proteins related to regulation of inflammation
(ROI) and regulatory/developmental function (RDP) were
similar in both sexes. However, in two cases we observed
marked differences in the response patterns between sexes
– especially in proteins involved in protease balance/
chaperone function (PBCF) and to a slightly lesser degree
in Nrf2-regulated proteins (NRF) (see Additional file 4
Table A and Table C). In the females there were only
about half as many significant changes in the WT and SP-
A treated groups relative to KO as in the males. However
we observed an interesting trend in these two functional
groups. In both groups (PBCF and NRF), the relative
numbers of proteins expressed at decreased levels in WT
relative to KO were comparable in both sexes, but when
mice were treated with SP-A, the pattern shifted substan-
tially in females and much less so in males. Indeed, within
6 hr of SP-A treatment, while males [29] continued to ex-
press most of the proteins in each group at lower levels
than in KO, in the females many more proteins were
expressed at higher levels than in KO. This trend was
moderated somewhat by 18 hr after SP-A treatment, but
although the relative numbers of increased and decreased
proteins versus KO in these two functional groups were
almost identical to the WT/KO comparison in males, they
were still quite different in females. These sex differences
may be the basis for differential responses and sensitivity
to oxidative stress and its consequences between the sexes
[5,112-114].
Although there seems to be an interaction between
sex and the effect of SP-A, it is unclear at this pointwhat the responsible mechanisms are. However, there
were several proteins that were expressed at significantly
higher levels in females than in males in WT or in KO
mice that are known to interact with the estrogen recep-
tor and may play a role in this interaction. These include
the major vault protein [105], chaperonin subunit 2
(beta) (CCT2), Rho GDP dissociation inhibitor alpha
[108], and heat shock protein 1 beta. The major vault
protein is induced by a variety of cellular stresses [115]
and has been implicated in defense against bacterial in-
fection [116]. We speculate that its higher levels and es-
trogen dependence in the female [105] contributes to
the survival advantage we previously reported in females
infected with K. pneumoniae [21].
If the changes in protein expression and SP-A respon-
siveness are indeed due to the influence of circulating
estrogen, as is the case with the female survival advan-
tage against K. pneumoniae infection [24], it is possible
that these changes in expression may vary somewhat
with the alterations in estrogen levels accompanying the
various stages of the estrous cycle. However, since cycle
stage was not determined in this study it is not possible
to determine whether the effects reported here are estro-
gen dose-dependent or whether they are just due to the
presence of estrogen in the circulation.
A number of studies have compared inflammatory me-
chanisms in males and females and evidence continues
to increase that differences in these mechanisms are the
basis for sex-specific differences in the severity and cli-
nical course of lung diseases with an inflammatory com-
ponent. Estrogens have been described as having a more
efficient and protective role in an animal model of lung
inflammation [117], as well as in other inflammatory
contexts [118], and have been characterized as important
pleiotropic regulators of inflammatory function [119,120].
We postulate that a dynamic interaction between SP-A
and estrogen in terms of regulating chaperones, proteases,
and proteins regulated by Nrf2 in the lung may be respon-
sible for these sex differences.
Conclusions
The AM proteome is markedly different in KO mice
than in WT mice, but rescue with exogenous SP-A res-
tores many of the characteristics of the WT AM pro-
teome to KO mice not only as shown in males [29], but
also in females (present study). However, although the
magnitude and extent of the SP-A-related changes seems
to be more pronounced in male mice, with the expres-
sion of many more proteins being significantly altered in
response to SP-A, the females undergo very pronounced
changes in the expression of two protein groups (protease
balance/chaperone function and Nrf2-related) that appear
to be more affected in the females than in the males.
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Animals
This study was done using pathogen-free WT and SP-A
KO female mice on the C57BL/6 genetic background.
WT mice were obtained from Jackson Laboratories (Bar
Harbor, ME). Breeder pairs of SP-A KO mice had been
obtained from Dr. Samuel Hawgood at the University of
California, San Francisco and were propagated and raised
under specific pathogen-free conditions in a barrier facility
at the Penn State College of Medicine [121]. The SP-A
KO mice and sentinel mice housed in the same room
showed no evidence of respiratory pathogens. The Institu-
tional Animal Care and Use Committee at the Penn State
College of Medicine approved this study.
This study used a total of 16, 25–34 g C57BL/6 WT
and SP-A KO female mice. These were divided into four
groups with 4 animals per group: 1) SP-A KO control
(baseline) mice that did not receive any treatment; 2)
SP-A KO mice that were treated with SP-A and sacri-
ficed 6 hr after treatment; 3) SP-A KO mice that were
treated with SP-A and sacrificed 18 hr after SP-A
treatment; and 4) WT control (baseline) mice that did
not receive any treatment. The female mice used in
this study were compared to male mice that had under-
gone identical manipulations and described in detail previ-
ously [29].SP-A preparation
SP-A was purified from the BAL fluid from normal
human lungs obtained from organ donors. The proto-
col was approved by the Penn State College of Medi-
cine Institutional Review Board. Donor lungs were
lavaged with 0.9% saline and the lavage fluid collected
and centrifuged at 150 × g for 10 min at 4°C to obtain
cell-free BAL. SP-A was then purified by repeated pre-
cipitation with 5 mM calcium chloride after which its
purity was checked by 1D-PAGE with silver stain and
by Western blot and determined to be greater than 99
percent pure. We also performed an LPS determi-
nation with the QCL-1000 Limulus Amebocyte Lysate
assay (Lonza, Walkersville, MD) and found the LPS content
of a 1 μg sample of SP-A to be below the detectable limit of
the assay (0.1 EU/ml) or < 500 fg of LPS/μg of SP-A.Treatment of mice with SP-A and collection of alveolar
macrophages
Experimental manipulations and harvesting of samples
has been described in detail previously [29]. Briefly, the
mice were anesthetized with Ketamine HCl (Ketaject,
Phoenix Pharmaceuticals Inc., St. Joseph, MO) and Xyla-
zine (XYLA-JECT, Phoenix Pharmaceuticals Inc., St.
Joseph, MO) and SP-A was instilled intrapharyngeally
with 5 μg of normal human SP-A in 50 μL of 0.9%sodium chloride containing 2 mM calcium chloride. The
5 μg dose of SP-A/mouse was based on our SP-A de-
terminations of total BAL SP-A from C57BL/6 mice
(mean 3.2 μg; n = 9) and a previous study that found this
dose to be sufficient to produce tubular myelin in the
BAL of SP-A KO mice [122].
To obtain AM mice were anesthetized and subjected
to BAL at intervals of 6 hr and 18 hr following treatment
with SP-A. Six hours was chosen as our initial time
point because a previous study found tubular myelin at
that time [122]. Furthermore, we postulated that this
time interval would be sufficient for new protein synthe-
sis to occur in response to SP-A treatment. The 18 hr
time point was chosen to determine the longer term
effects of a single dose of SP-A, that could potentially in-
clude the consequences of the indirect effects of SP-A.
AM were obtained by performing BAL with PBS, 1 mM
EDTA using a volume equal to 80% of lung vital capacity
(5 times with 0.5 mL) for a total of 2.5 ml. The fluid was
instilled and withdrawn 3 times with chest massage du-
ring withdrawal, then centrifuged at 150 × g for 5 min at
4°C and the cell pellet washed with 1 mL of PBS, 1 mM
EDTA. Cells were counted to obtain total and differential
cell counts before being frozen at −80°C for subsequent
proteomic studies.
To prepare AM for 2D-DIGE frozen AM pellets were
lyophilized until completely dry and resuspended in 25
μL of standard cell lysis buffer (30 mM Tris–HCl, 2 M
thiourea, 7 M urea, 4% CHAPS, pH 8.5). Protein deter-
minations were done using the Bio-Rad Protein Assay
(Bio-Rad, Hercules, CA) and the concentration of protein
was adjusted to 1 mg/ml for CyDye labeling.
CyDye labeling (minimal labeling) and electrophoresis for
2D-DIGE
These procedures have been described in detail pre-
viously [29,30,123]. Information about the 2D-DIGE
study is provided in a form that complies with the
most recent version <http://www.psidev.info/miape/MIA
PE_GE_1_4.pdf> of Minimum Information About a Pro-
teomics Experiment – Gel Electrophoresis (MIAPE-GE)
standards currently under development by the Human
Proteome Organization Proteomics Standards Initiative
(see Additional file 6).
Gel imaging, image analysis, and statistics
Information about the acquisition and processing of data
from the 2D-DIGE studies are provided in the form that
complies with the most recent version of the guidelines
established for Minimum Information about a Proteo-
mics Experiment – Gel Informatics (MIAPE-GI) currently
under development by the Human Proteome Organi-
zation Proteomics Standards Initiative http://www.psidev.
info/files/miape-gi-v1.pdf (see Additional file 7). Gel
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v4.0 program (Nonlinear Dynamics) for analysis. For
identified proteins having multiple isoforms, the nor-
malized volumes of all isoforms of a given protein
were added together and statistical analysis was per-
formed on the totals using Microsoft Excel.
Protein identification by mass spectrometry
We have used this procedure in previous studies for
other types of protein samples [28,30,123] and we re-
cently published a detailed account including many
modifications and refinements [29].
All 791 gel spots were picked robotically and pro-
cessed for analysis by MALDI-ToF/ToF mass spec-
trometry (5800 Proteomic Analyzer Applied
Biosystems, Foster City, CA) in the Mass Spectrom-
etry Core at the Penn State University College of
Medicine. The MS and MS/MS data were submitted
to the MASCOT search engine using the NCBI non-
redundant database and mouse taxonomy for identi-
fication. The search parameters included: trypsin
digestion with a maximum of three missed cleavages;
fixed modifications, carbamidomethylation; variable modi-
fications, carbamylation, acetylation, deamidation, oxida-
tion; peptide mass tolerance, 0.15 Da. MASCOT
confidence interval scores of > 95% combined with a Pro-
teinPilot score of greater than 61 were considered as a
positive protein identification. An image of the reference
gel is shown in Additional file 2 with all identified proteins
circled and numbered. From the 791 gel spots analyzed,
290 spots were identified resulting in 76 unique proteins.
The PANTHER database and the scientific litera-
ture were used to provisionally assign molecular
function and biological process to each identified
protein. We then re-assigned the identified proteins
to five broad functional classes as we described pre-
viously [29] including: a) actin-related/cytoskeletal
proteins; b) proteins involved in protease balance/
chaperone function; c) proteins involved in regula-
tion of inflammation; d) proteins involved in regula-
tory/differentiative processes; and e) proteins
regulated by Nrf2. It should be noted that some pro-
teins are in more than one functional group. This
classification scheme was more inclusive than relying
solely on the biological function classification pro-
vided by PANTHER and similar gene ontology data-
bases. We also used the Ingenuity Pathway Analysis
program (Ingenuity Systems, Redwood City, CA) to
gain additional insight into the functional signifi-
cance of the observed changes. Protein names, acces-
sion numbers, and the functional groups we assigned
them to are listed in Additional file 1 together with
a list of supporting references.Additional files
Additional file 1: File format: doc. Title: Protein names and cross
references to accession numbers and categories. Description: File
containing a table that has the gel numbers and names of all identified
proteins. It contains both NCBI GI numbers and Swiss Prot Accession
numbers for all proteins, as well as the designation for the functional
group(s) to which each protein was assigned. The citations used to
assign each protein to the designated functional category are part of the
reference list for the main article.
Additional file 2: Reference gel (same as in male study). Description:
Spot map showing location of all identified proteins.
Additional file 3: Title: Values for all identified female alveolar
macrophage proteins with note of significant changes. Description:
File containing a table that gives normalized volumes for all proteins for
each individual group +/− SD and indicates comparisons between
groups that were significantly different.
Additional file 4: Tables A – F. Tables for each protein functional
group (Tables A-E) and for all proteins (Table F) summarizing changes of
each female group relative to KO baseline values. The data for each
functional group (Tables A-E) are extracted from the complete list
presented in Table F.
Additional file 5: Tables A – F. Tables for each protein functional
group (Tables A-E) and for all proteins (Table F) summarizing sex
differences for each treatment group. The data for each functional group
(Tables A-E) are extracted from the complete list presented in Table F.
Additional file 6: Title: MIAPE: Gel Electrophoresis. Description: File
containing Minimum Information About a Proteomics Experiment – Gel
Electrophoresis in the format recommended by the Human Proteome
Organization Proteomic Standards Initiative.
Additional file 7: Title: MIAPE: Gel Informatics. Description: File
containing Minimum Information About a Proteomics Experiment – Gel
Informatics in the format recommended by the Human Proteome
Organization Proteomic Standards Initiative.
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